Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
ELVN
Enliven Therapeutics
$20.30
Login to display Enliven Therapeutics (ELVN) recommendation from the last 90 days from financial news and social media. Chart
$20.95 (-3.10%)
$19.93 (+1.86%)
$18.63 (+8.96%)
$27.75 (-26.85%)
ELVN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
ELVN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ELVN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ELVN Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayELVN Earnings
The TTM reflects 12-month period, providing review of ELVN financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is ELVN current stock price?
What are ELVN stock strengths?
What risks are associated with ELVN stock?
When is ELVN next earnings report?
What is ELVN market cap and volume?
What is ELVN's current Stock IQ?
Should I buy ELVN stock right now?
Is ELVN a Strong Buy right now?
What does a 'Strong Buy' rating mean for ELVN?
What does a 'Strong Sell' rating mean for ELVN?
What factors influence ELVN's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
ELVN
Enliven Therapeutics
Current Price
$20.30
Stock Insights
Not Enough Information
Login to view Enliven Therapeutics (ELVN) recommendation from the last 90 days from financial news and social media.
Chart
$20.95 (-3.10%)
$19.93 (+1.86%)
$18.63 (+8.96%)
$27.75 (-26.85%)
ELVN Analysts Opinion
ELVN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
ELVN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ELVN Street view is bullish and have positive views on the near-term outlook
ELVN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayELVN Earnings
The TTM data reflects the most recent 12-month period, providing overview of ELVN financial performance.
ELVN Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
ELVN Latest Analysis
Enliven Therapeutics Inc. (ELVN) Presents at 13th Annual Meeting of the Society of Hematologic Oncology - Slideshow.
Fri Sep 12, 2025
Wall Street Analysts Predict a 106.48% Upside in Enliven Therapeutics Inc. (ELVN): Heres What You Should Know. The average of price targets set by Wall Street analysts indicates a potential upside of 106.5% in Enliven Therapeutics Inc. (ELVN). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.
Fri Sep 12, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ELVN Stock trends
ELVN Stock performance
ELVN Stock analysis
ELVN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings